SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Stealth Peptides Inc. Announces FDA IND Approval for Conduct of Clinical Studies with Bendavia(TM), A Mitochondrial Targeted Therapy for Ischemia Reperfusion Injury